Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.64M | -113.50M | -117.26M | -88.42M | -91.36M |
| Total Depreciation and Amortization | 2.57M | 3.44M | 4.28M | 4.88M | 4.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.02M | 40.24M | 38.85M | 6.98M | 6.12M |
| Change in Net Operating Assets | -4.90M | -361.00K | -4.43M | 8.20M | 13.39M |
| Cash from Operations | -67.95M | -70.18M | -78.56M | -68.35M | -67.27M |
| Capital Expenditure | -317.00K | -420.00K | -518.00K | -1.89M | -6.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.31M | -20.61M | 44.51M | 28.20M | 12.73M |
| Cash from Investing | -27.63M | -21.03M | 43.99M | 26.31M | 6.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 88.72M | 88.73M | 685.00K | 1.24M | 1.84M |
| Repurchase of Common Stock | -2.92M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.80M | 88.73M | 685.00K | 1.24M | 1.84M |
| Foreign Exchange rate Adjustments | 70.00K | 39.00K | 64.00K | -15.00K | -13.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.70M | -2.45M | -33.82M | -40.82M | -59.31M |